Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-05 Sale |
2021-04-06 5:46 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
17,107 | $43.39 | $742,323 | 266,323 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-06 5:43 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
25,211 | $43.4 | $1,094,032 | 1,073,983 (Indirect Direct) |
View |
| 2021-04-05 Sale |
2021-04-06 5:40 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
64,562 | $43.43 | $2,803,800 | 2,890,713 (Indirect Direct) |
View |
| 2021-04-05 Sale |
2021-04-05 7:54 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
12,897 | $43.5 | $561,021 | 88,855 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 7:49 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
4,210 | $43.45 | $182,917 | 1,099,194 (Indirect Direct) |
View |
| 2021-03-10 Sale |
2021-03-10 8:26 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
4,720 | $45.24 | $213,542 | 58,940 (Indirect) |
View |
| 2021-03-03 Sale |
2021-03-08 06:03 am |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
3,700 | $45.07 | $166,747 | 63,660 (Indirect) |
View |
| 2021-03-01 Sale |
2021-03-03 4:37 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
4,210 | $41.65 | $175,352 | 1,111,824 (Indirect Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:37 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
26,794 | $41.7 | $1,117,225 | 2,955,275 (Indirect Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:36 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $41.69 | $416,858 | 563,942 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:35 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
3,083 | $41.67 | $128,482 | 283,430 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 5:56 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
26,794 | $37.5 | $1,004,837 | 2,938,319 (Indirect Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 5:56 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
3,083 | $37.56 | $115,805 | 271,513 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 5:55 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $37.49 | $374,865 | 560,192 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 5:55 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
4,210 | $37.51 | $157,918 | 1,097,284 (Indirect Direct) |
View |
| 2020-12-24 Sale(A) |
2021-02-03 5:54 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
18,473 | $55.99 | $1,034,260 | 580,192 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 8:25 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
26,794 | $52.06 | $1,394,907 | 2,965,113 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 8:25 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $51.93 | $519,323 | 570,192 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 8:25 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
34,987 | $52.05 | $1,821,116 | 1,101,493 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 8:24 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
3,083 | $51.91 | $160,034 | 274,596 (Direct) |
View |
| 2020-12-24 Sale |
2020-12-28 9:01 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
18,473 | $0 | $0 | 580,192 (Indirect Direct) |
View |
| 2020-12-04 Sale |
2020-12-08 8:38 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
36,739 | $54.99 | $2,020,269 | 598,665 (Indirect Direct) |
View |
| 2020-12-04 Sale |
2020-12-08 8:38 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
13,684 | $52.18 | $714,060 | 277,679 (Direct) |
View |
| 2020-12-04 Sale |
2020-12-08 8:37 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
23,057 | $52.18 | $1,203,162 | 1,138,080 (Indirect Direct) |
View |
| 2020-12-04 Sale |
2020-12-08 8:37 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
75,375 | $52.18 | $3,933,221 | 2,991,907 (Indirect Direct) |
View |
| 2020-12-01 Sale |
2020-12-03 6:30 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
500,000 | $50.5 | $25,250,000 | 3,943,284 (Indirect) |
View |
| 2020-12-01 Sale |
2020-12-03 5:57 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
8,420 | $52.96 | $445,883 | 1,161,137 (Indirect Direct) |
View |
| 2020-12-02 Sale |
2020-12-03 5:56 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $51.43 | $514,334 | 635,404 (Indirect Direct) |
View |
| 2020-12-02 Sale |
2020-12-03 5:56 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
26,794 | $51.4 | $1,377,344 | 3,067,282 (Indirect Direct) |
View |
| 2020-12-02 Sale |
2020-12-03 5:56 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
3,083 | $51.47 | $158,681 | 291,363 (Direct) |
View |
| 2020-11-23 Sale |
2020-11-25 8:33 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $46.54 | $465,381 | 645,404 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-11 Option Award |
2021-02-16 7:05 pm |
N/A 2031-02-10 |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
60,000 | $0 | 331,513 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 7:04 pm |
N/A 2031-02-10 |
Zentalis Pharmaceuticals Inc. | ZNTL | Pinto Alexis Chief Legal Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 7:02 pm |
N/A 2031-02-10 |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
75,000 | $0 | 1,172,284 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 7:02 pm |
N/A 2031-02-10 |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
175,000 | $0 | 3,113,319 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 7:01 pm |
N/A 2031-02-10 |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 7:01 pm |
N/A 2031-02-10 |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
55,000 | $0 | 615,192 (Direct) |
View |
| 2021-02-09 Option Award |
2021-02-10 09:41 am |
N/A 2031-02-08 |
Zentalis Pharmaceuticals Inc. | ZNTL | Kariuki Enoch Director |
42,000 | $0 | 42,000 (Direct) |
View |
| 2020-11-22 Gift |
2021-01-06 8:25 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
213,600 | $0 | 2,965,113 (Direct) |
View |
| 2020-12-24 Gift |
2021-01-06 8:25 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
1,600 | $0 | 1,101,493 (Direct) |
View |
| 2020-10-28 Other |
2020-10-30 7:53 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Recurium Equity LLC 10% Owner |
4,147,940 | $0 | 4,162,930 (Direct) |
View |